In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme Disease | Zendy

Kristina Morgenstern | Zendy; G. Baljer | Zendy; Douglas E. Norris | Zendy; Peter Kraiczy | Zendy; Christa Hanssen-Hübner | Zendy; Klaus-Peter Hunfeld | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme Disease

Author(s) -

Kristina Morgenstern,

G. Baljer,

Douglas E. Norris,

Peter Kraiczy,

Christa Hanssen-Hübner,

Klaus-Peter Hunfeld

Publication year - 2008

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01247-08

Subject(s) - lyme disease , borrelia , antimicrobial , microbiology and biotechnology , borrelia burgdorferi , biology , virology , in vitro , immunology , antibody , biochemistry

Ten isolates of the recently delineated genospeciesBorrelia spielmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern ofB. spielmanii mainly parallels that of the other known human-pathogenic members of theB. burgdorferi sensu lato complex.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research